Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in BIAF — bioAffinity Technologies, Inc.

CIK 1000275 TORONTO, A6
Back to BIAF Full portfolio

Position in BIAF

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$755
+$753 QoQ
Shares Held
62
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 20 holders
Holding Since
Sep 2022
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BIAF Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $3,424,927,781 across 36 Diagnostics & Research names. BIAF ranks #32 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 3,430,798 $1,720,064,877
2 DHR
Danaher Corp /De/
 2,393,859 $455,982,255
3 LH
Labcorp Holdings Inc.
 807,619 $226,133,320
4 IQV
Iqvia Holdings Inc.
 797,956 $154,181,053
5 IDXX
Idexx Laboratories Inc /De
 274,340 $144,423,545
6 A
Agilent Technologies, Inc.
 835,556 $110,986,898
7 WAT
Waters Corp /De/
 267,531 $100,334,819
8 NTRA
Natera, Inc.
 295,159 $80,120,905

All Filings in BIAF

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $755 931
2022-09-30 $2 1